Clinical Trials Logo

Clinical Trial Summary

This study will look at the change in participants' body weight from the start to the end of the study. The weight loss in participants taking semaglutide (a new medicine) will be compared to the weight loss of participants taking "dummy" medicine. In addition to taking the medicine, participants will have talks with study staff about healthy food choices, how to be more physically active and what you can do to lose weight. Participants will either get semaglutide or "dummy" medicine - which treatment participants get, is decided by chance. Participants will need to take 1 injection once a week. The study medicine is injected with a thin needle in a skin fold in the stomach, thigh or upper arm. The study has two phases: A main phase and an extension phase.The main phase will last for about 1.5 years. Participants will have 15 clinic visits and 10 phone calls with the study doctor. Extension phase: Approximately 300 participants will continue in the extension phase in the following countries only: Canada, Germany, the UK and selected sites in the US and Japan. These participants will be in the study for about 2.5 years.They will not receive treatment, but will attend another 5 follow-up visits with the study doctor.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03548935
Study type Interventional
Source Novo Nordisk A/S
Contact
Status Completed
Phase Phase 3
Start date June 4, 2018
Completion date March 5, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT06013163 - A Phase 1 Study to Evaluate EMP22 PD and EMP16 PK Versus Xenical® in Healthy Volunteers Phase 1
Active, not recruiting NCT03843424 - Treatment Efforts Addressing Child Weight Management by Unifying Patients, Parents & Providers N/A
Not yet recruiting NCT06360536 - Remotely Delivered Resistance Training for Cardiometabolic Health Among Black Women N/A
Not yet recruiting NCT05997576 - A Study of TG103 Injection in Non-diabetic Overweight or Obesity Phase 3
Recruiting NCT04763291 - Cardiovascular and InflammAging Study N/A
Active, not recruiting NCT04399460 - The Effects of Long-term Consumption of Full-fat Dairy Products on Satiety, Body Weight and Glycemic Control N/A
Completed NCT04451824 - Examination of Circumferential Reduction N/A
Completed NCT04110717 - Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control as a Means of Reducing Excess Body Weight N/A
Completed NCT05561855 - T2DM Intensity Lifestyle Intervention N/A
Active, not recruiting NCT04100200 - Berries, Inflammation, and Gut Microbiome N/A
Recruiting NCT06125964 - eMOTION Formative Study N/A
Recruiting NCT06087822 - Multicenter Trial Investigating Performance and Safety of the Medical Device SiPore21® N/A
Active, not recruiting NCT04328233 - Impact of Time-Restricted Eating on Metabolic Homeostasis, Inflammation and Oxidative Stress in Metabolic Syndrome N/A
Completed NCT06091761 - Thread Embedding Acupuncture Combined With Auricular Acupuncture for Overweight and Obesity N/A
Completed NCT04894344 - Education to Decrease in Sodium Intake Evaluated With 24 Hour Urinary Sodium Excretion (RCT) N/A
Completed NCT05713461 - Physical Exercise in Obesity for Health and Quality of Life. N/A
Not yet recruiting NCT06054698 - Efficacy and Safety of HRS9531 Injections in Overweight or Obese Subjects Phase 2
Not yet recruiting NCT02823912 - Capsaicin Effect on Cytokines Profile in Dyslipidemia Phase 2/Phase 3
Completed NCT05104151 - Efficacy of a Nutritive Bar, in Reduction of Weight, Body Fat and Control of Appetite N/A
Completed NCT04786925 - Precision Nutrition Strategies for Improving the Quality of Life of Pre-senior and Senior Populations N/A